Assessment of Gastrointestinal Autonomic Dysfunction: Present and Future Perspectives
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
The autonomic nervous system delicately regulates the function of several target organs, including the gastrointestinal tract. Thus, nerve lesions or other nerve pathologies may cause autonomic dysfunction (AD). Some of the most common causes of AD are diabetes mellitus and α-synucleinopathies such as Parkinson’s disease. Widespread dysmotility throughout the gastrointestinal tract is a common finding in AD, but no commercially available method exists for direct verification of enteric dysfunction. Thus, assessing segmental enteric physiological function is recommended to aid diagnostics and guide treatment. Several established assessment methods exist, but disadvantages such as lack of standardization, exposure to radiation, advanced data interpretation, or high cost, limit their utility. Emerging methods, including high-resolution colonic manometry, 3D-transit, advanced imaging methods, analysis of gut biopsies, and microbiota, may all assist in the evaluation of gastroenteropathy related to AD. This review provides an overview of established and emerging assessment methods of physiological function within the gut and assessment methods of autonomic neuropathy outside the gut, especially in regards to clinical performance, strengths, and limitations for each method.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602
The gut microbiota and host health: a new clinical frontier
Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D. A., Hirschfield, G. M., Hold, G., Quraishi, M. N., Kinross, J., Smidt, H., Tuohy, K. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309990 · Cited by 2,302
Freeman, R., Wieling, W., Axelrod, F. B., Benditt, D. G., Benarroch, E., Biaggioni, I., Cheshire, W. P., Chelimsky, T., Cortelli, P., Gibbons, C. H., et al. (2011) · Clinical Autonomic Research · doi:10.1007/s10286-011-0119-5 · Cited by 1,697
Colonic bacterial composition in Parkinson's disease
Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., & Shannon, K. M. (2015) · Movement Disorders · doi:10.1002/mds.26307 · Cited by 1,281 · cited 1×
“Improvement of glycemic control and variability is important in patients with DM to reduce the risk of dysmotility due to hyper-or hypoglycemia.”
BackgroundFreeman, R., Wieling, W., Axelrod, F. B., Benditt, D. G., Benarroch, E., Biaggioni, I., Cheshire, W. P., Chelimsky, T., Cortelli, P., Gibbons, C. H., et al. (2011) · Autonomic Neuroscience · doi:10.1016/j.autneu.2011.02.004 · Cited by 1,243
Gastrointestinal Dysfunction in Parkinson’s Disease
Fasano, A., Visanji, N. P., Liu, L. W. C., Lang, A. E., & Pfeiffer, R. F. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00007-1 · Cited by 1,016
Spallone, V., Ziegler, D., Freeman, R., Bernardi, L., Frontoni, S., Pop‐Busui, R., Stevens, M., Kempler, P., Hilsted, J., Tesfaye, S., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1239 · Cited by 957 · cited 1×
“Optimized future diagnostic tools and improved knowledge on motility disturbances in gastroenteropathy related to AD will hopefully improve the treatment of these severely ill patients.”
BackgroundSimplified assessment of segmental colonic transit
Metcalf, A. M., Phillips, S. F., Zinsmeister, A. R., MacCarty, R. L., Beart, R. W., & Wolff, B. G. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90837-7 · Cited by 928 · cited 1×
“If quantitative data are needed, a capsule containing 10 markers is ingested on 6 consecutive days with an abdominal X-ray on day 7 [79,80].”
MethodToward defining the autoimmune microbiome for type 1 diabetes
Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Novelo, L. L., Casella, G., Drew, J. C., Ilonen, J., Knip, M., Hyöty, H., et al. (2011) · The ISME Journal · doi:10.1038/ismej.2010.92 · Cited by 806
Brown, C. T., Davis-Richardson, A. G., Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Casella, G., Drew, J. C., Ilonen, J., Knip, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025792 · Cited by 778 · cited 1×
“However, prokinetic treat-ment has major limitations, especially the risk of extrapyramidal side effects including potentially irreversible tardive dyskinesia (metoclopramide), drug-induced arrhythmias (domperidone), and lack of evidence for long-term effectiveness [177,178].”
BackgroundDisorders of gastrointestinal motility associated with diabetes mellitus
FELDMAN, M., & SCHILLER, L. R. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-3-378 · Cited by 653
Bytzer, P., Talley, N. J., Leemon, M., Young, L. J., Jones, M. P., & Horowitz, M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.16.1989 · Cited by 632 · cited 1×
“Common GI symptoms, such as dysphagia, nausea, vomiting, bloating, early satiety, abdominal pain, constipation, diarrhea, weight loss, and fecal incontinence may be present, combined or solitary, and they may substantially affect the quality of life [22–24].”
BackgroundIntestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease
Hasegawa, S., Goto, S., Tsuji, H., Okuno, T., Asahara, T., Nomoto, K., Shibata, A., Fujisawa, Y., Minato, T., Okamoto, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142164 · Cited by 523 · cited 1×
“To preserve a sufficient nutritional state, a feeding tube may be necessary for selected patients with weight loss.”
BackgroundLebouvier, T., Neunlist, M., Bruley des Varannes, S., Coron, E., Drouard, A., N'Guyen, J.-M., Chaumette, T., Tasselli, M., Paillusson, S., Flamand, M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012728 · Cited by 427 · cited 1×
“An understanding of the human gut microbial diversity in different types of disorders might provide insight into the clinical application in diagnosis and treatments of disease.”
BackgroundRentz, A. M., Kahrilas, P., Stanghellini, V., Tack, J., Talley, N. J., De la loge, C., Trudeau, E., Dubois, D., & Revicki, D. A. (2004) · Quality of Life Research · doi:10.1007/s11136-004-9567-x · Cited by 406 · cited 2×
“PAGI-SYM (patient assessment of upper gastrointestinal disorders-symptom severity index) [39].”
Techniques used to characterize the gut microbiota: a guide for the clinician
Fraher, M. H., O'Toole, P. W., & Quigley, E. M. M. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.44 · Cited by 385
Postural tachycardia syndrome: a heterogeneous and multifactorial disorder
Benarroch, E. E. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.08.013 · Cited by 370 · cited 1×
“The rise in heart rate is seen in the absence of ortho-static hypotension and symptoms of orthostatic intolerance must be present for at least 6 months [15].”
BackgroundYu, D., Cheeseman, F., & Vanner, S. (2011) · Gut · doi:10.1136/gut.2009.205476 · Cited by 284
Bharucha, A. E., Kudva, Y. C., & Prichard, D. O. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00161 · Cited by 252
Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life
Talley, N. J., Young, L., Bytzer, P., Hammer, J., Leemon, M., Jones, M., & Horowitz, M. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03350.x · Cited by 220
Dietary Intake and Nutritional Deficiencies in Patients With Diabetic or Idiopathic Gastroparesis
Parkman, H. P., Yates, K. P., Hasler, W. L., Nguyan, L., Pasricha, P. J., Snape, W. J., Farrugia, G., Calles, J., Koch, K. L., Abell, T. L., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.045 · Cited by 198
Abrahamsson, H., Antov, S., & Bosaeus, I. (1988) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528809095938 · Cited by 179 · cited 1×
“Jejunal aspirates for culture did not correlate well with the breath test, and in general methods for diagnosing SIBO lack sensitivity, specificity, reproducibility, and standardization [90].”
BackgroundPrevalence of small intestinal bacterial overgrowth in Parkinson’s disease
Gabrielli, M., Bonazzi, P., Scarpellini, E., Bendia, E., Lauritano, E. C., Fasano, A., Ceravolo, M. G., Capecci, M., Rita Bentivoglio, A., Provinciali, L., et al. (2011) · Movement Disorders · doi:10.1002/mds.23566 · Cited by 175
Gastric electrical stimulation improves outcomes of patients with gastroparesis for up to 10 years
McCallum, R. W., Lin, Z., Forster, J., Roeser, K., Hou, Q., & Sarosiek, I. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.12.013 · Cited by 169
Best practices in modified barium swallow studies
Martin-Harris, B., Canon, C. L., Bonilha, H. S., Murray, J., Davidson, K., & Lefton-Greif, M. A. (2020) · American Journal of Speech-Language Pathology · doi:10.1044/2020_ajslp-19-00189 · Cited by 129 · cited 2×
“Unfortunately, this examination suffers a highly variable inter- and intra-rater reliability, requires considerable resources, and is associated to radiation exposure as well as aspiration risks [56,58].”
BackgroundMethodBeckers, A. B., Keszthelyi, D., Fikree, A., Vork, L., Masclee, A., Farmer, A. D., & Aziz, Q. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13013 · Cited by 90 · cited 2×
“Prominent multi-segmental GI symptoms are also commonly seen in the hypermobile Ehlers–Danlos syndrome and in the mast cell activation syndrome, which is relevant as a differential diagnosis [16,17].”
BackgroundIntestinal Permeability and Orocaecal Transit Time in Elderly Patients with Parkinson’s Disease
Davies, K. N., King, D., Billington, D., & Barrett, J. A. (1996) · Postgraduate Medical Journal · doi:10.1136/pgmj.72.845.164 · Cited by 88
Diabetic Enteropathy: From Molecule to Mechanism-Based Treatment
Meldgaard, T., Olesen, S. S., Farmer, A. D., Krogh, K., Wendel, A. A., Brock, B., Drewes, A. M., & Brock, C. (2018) · Journal of Diabetes Research · doi:10.1155/2018/3827301 · Cited by 83
Self-citationPancreatic polypeptide: a unique model for vagal control of endocrine systems
Schwartz, T. W. (1983) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(83)90134-0 · Cited by 71
The clinical approach to autonomic failure in neurological disorders
Benarroch, E. E. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.88 · Cited by 71
Haase, A. M., Gregersen, T., Schlageter, V., Scott, M. S., Demierre, M., Kucera, P., Dahlerup, J. F., & Krogh, K. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12461 · Cited by 63
Self-citationMast Cell Activation Syndrome: A Primer for the Gastroenterologist
Weinstock, L. B., Pace, L. A., Rezaie, A., Afrin, L. B., & Molderings, G. J. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06264-9 · Cited by 59 · cited 7×
“In addition, mast cells and ICC in enteric biopsies can be visualized and counted microscopically by staining with C-kit/CD117 [16,138] A new approach is non-invasive mapping of full-thickness segments of the gut and identification and quan-tification of ganglia of the enteric nervous system by a technique named optical…”
BackgroundMethodInfluentialTechnique of Functional and Motility Test: How to Perform Antroduodenal Manometry
Patcharatrakul, T., & Gonlachanvit, S. (2013) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2013.19.3.395 · Cited by 58 · cited 1×
“Thus, the method has only gained limited use in AD-related gastroenteropathies [76].”
MethodAlomari, M., Hitawala, A., Chadalavada, P., Covut, F., Al Momani, L., Khazaaleh, S., Gosai, F., Al Ashi, S., Abushahin, A., & Schneider, A. (2020) · Cureus · doi:10.7759/cureus.7881 · Cited by 53 · cited 1×
“Normal lung and liver function are also a prerequisite.”
BackgroundGastrointestinal dysfunction in postural tachycardia syndrome
Wang, L. B., Culbertson, C. J., Deb, A., Morgenshtern, K., Huang, H., & Hohler, A. D. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.10.052 · Cited by 45 · cited 1×
“Orthostatic symptoms in POTS often coexist with severe GI symptoms, with nausea, abdominal pain and constipation reported in more than 70% [29,30].”
BackgroundFikree, A., Aziz, Q., & Sifrim, D. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13029 · Cited by 30
Menys, A., Keszthelyi, D., Fitzke, H., Fikree, A., Atkinson, D., Aziz, Q., & Taylor, S. A. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13090 · Cited by 26
Cited by
Enteric neuropathy in diabetes: Implications for gastrointestinal function
Abdalla, M. M. I. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i22.2852 · Cited by 45
Patterns of Food Selectivity among Children with Autism Spectrum Disorders
Byrska, A., Błażejczyk, I., Faruga, A., Potaczek, M., Wilczyński, K. M., & Janas-Kozik, M. (2023) · doi:10.20944/preprints202307.0875.v1 · Cited by 37
“The study also reported impaired sympathetic vasoconstriction in ASD, pointing to a complex autonomic dysfunction that intermittently influences cardiovascular and thermoregulatory responses [47].”
BackgroundWifi, M.-N., El-Sherbiny, M., Mohamed, R. S., Kandeel, A., & Rizk, S. E. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03977-x · Cited by 3
Metadata
- Authors
- Kornum, D. S., Terkelsen, A. J., Bertoli, D., Klinge, M. W., Høyer, K. L., Kufaishi, H. H. A., Borghammer, P., Drewes, A. M., Brock, C., & Krogh, K.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2021-03-31
- Volume
- 10
- Issue
- 7
- Pages
- 1392
- ISSN
- 2077-0383 (ISSN-L)
- OpenAlex
- W3144563614
- Cited by
- 47
- References
- 38
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.